Physician

Anjana Khuntia, MD

According to 2025 Medicare claims, Anjana Khuntia, MD (NPI: 1467502401) practices allergy/immunology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is PSF PLLC (NPI: 1881785947; TIN: 611389493) and primary practice location at 19464-3285.

Khuntia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 114 traditional Medicare patients, billed 5,594 HCPCS/CPT codes, and received $111,913 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 759 prescription claims across 115 beneficiaries totaling $169,121 in drug costs, led by Spiriva Respimat (Tiotropium Bromide). DME data shows 111 claims. Open Payments data shows 31 records totaling $6,600. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $15,016 to $111,913. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $79,501 to $169,121. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $605 to $3,129.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	56	1,054	$15,016
2016	62	864	$16,213
2017	85	1,125	$20,527
2018	86	1,215	$19,954
2019	84	1,335	$27,275
2020	83	1,832	$40,410
2021	107	1,905	$36,944
2022	120	4,117	$90,419
2023	121	4,246	$88,404
2024	114	5,594	$111,913

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	267	$79,501
2016	53	303	$63,593
2017	56	279	$55,208
2018	55	335	$77,286
2019	80	423	$97,575
2020	69	502	$143,791
2021	83	512	$157,718
2022	89	662	$205,415
2023	103	720	$217,667
2024	115	759	$169,121

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$259
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	33	$52,224
2022	N/R	70	$56,596
2023	N/R	71	$1,938
2024	N/R	111	$124,065

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	27	27	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	62	111	$93
94375	Test to measure rate of airflow	56	86	$29
95004	Test for allergy using allergenic extract	30	2,087	$3
96160	Administration and interpretation of patient-focused health risk assessment	47	80	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Spiriva Respimat	Tiotropium Bromide	39	2,160	$36,046
Symbicort	Budesonide/Formoterol Fumarate	59	3,320	$23,447
Advair Hfa	Fluticasone Propion/Salmeterol	24	1,440	$17,908
Dulera	Mometasone/Formoterol	27	1,260	$14,274
Incruse Ellipta	Umeclidinium Bromide	25	1,230	$13,364

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	24	$121,195
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	31	$2,284
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	31	$378
E0779	Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater	Y	N/R	12	$163
E0570	Nebulizer, with compressor	Y	N/R	13	$45

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$351	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	19	$6,249	Regeneron Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anjana Khuntia, MD?

Tedicare shows public-source Medicare data for Anjana Khuntia, MD (NPI 1467502401), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anjana Khuntia, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anjana Khuntia, MD?

Anjana Khuntia, MD is linked to PSF PLLC (billing NPI 1881785947) in the available physician profile data.

Does Anjana Khuntia, MD have Open Payments data?

Anjana Khuntia, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.